Vietnamese crab exporter

Get 37% off on an annual Print + Digital subscription of India Today Magazine

Gujarat | A dark warning for 2027

Gujarat industry faces the early effects of 'super' El Nino in sudden power cuts

Advertisement

Patients with breast, prostate, lung and colorectal cancers are among those set to benefit from sharp reductions in anti-cancer drug prices from November 9. The National Pharmaceutical Pricing Authority (NPPA) has revised prices of 1,366 cancer drug brands, with prices falling by over 90 per cent for select generic and biosimilar medicines. The trade margins rationalisation could save Rs 2,500 crore for patients annually.

advertisement